annual FCF:
-$37.44M+$39.09M(+51.07%)Summary
- As of today (May 24, 2025), FOLD annual free cash flow is -$37.44 million, with the most recent change of +$39.09 million (+51.07%) on December 31, 2024.
- During the last 3 years, FOLD annual FCF has risen by +$168.93 million (+81.86%).
- FOLD annual FCF is now -357.83% below its all-time high of $14.52 million, reached on December 31, 2007.
Performance
FOLD Free cash flow Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly FCF:
$7.55M+$11.75M(+279.50%)Summary
- As of today (May 24, 2025), FOLD quarterly free cash flow is $7.55 million, with the most recent change of +$11.75 million (+279.50%) on March 31, 2025.
- Over the past year, FOLD quarterly FCF has increased by +$39.05 million (+123.95%).
- FOLD quarterly FCF is now -82.13% below its all-time high of $42.22 million, reached on December 31, 2007.
Performance
FOLD quarterly FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM FCF:
$1.61M+$39.05M(+104.29%)Summary
- As of today (May 24, 2025), FOLD TTM free cash flow is $1.61 million, with the most recent change of +$39.05 million (+104.29%) on March 31, 2025.
- Over the past year, FOLD TTM FCF has increased by +$89.63 million (+101.83%).
- FOLD TTM FCF is now -91.98% below its all-time high of $20.05 million, reached on June 30, 2008.
Performance
FOLD TTM FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Free cash flow Formula
FCF = Cash From Operations − CAPEX
FOLD Free cash flow Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +51.1% | +124.0% | +101.8% |
| 3 y3 years | +81.9% | +112.8% | +100.8% |
| 5 y5 years | +86.2% | +106.9% | +100.5% |
FOLD Free cash flow Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +81.9% | -65.0% | +109.0% | at high | +100.8% |
| 5 y | 5-year | at high | +86.2% | -65.0% | +106.9% | at high | +100.5% |
| alltime | all time | -357.8% | +87.8% | -82.1% | +105.6% | -92.0% | +100.5% |
FOLD Free cash flow History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2025 | - | $7.55M(-279.5%) | $1.61M(-104.3%) |
| Dec 2024 | -$37.44M(-51.1%) | -$4.20M(-82.0%) | -$37.44M(+18.8%) |
| Sep 2024 | - | -$23.33M(-208.0%) | -$31.51M(-34.5%) |
| Jun 2024 | - | $21.59M(-168.5%) | -$48.10M(-45.4%) |
| Mar 2024 | - | -$31.51M(-1924.3%) | -$88.03M(+15.0%) |
| Dec 2023 | -$76.53M(-55.1%) | $1.73M(-104.3%) | -$76.53M(-52.7%) |
| Sep 2023 | - | -$39.91M(+117.7%) | -$161.71M(+21.3%) |
| Jun 2023 | - | -$18.34M(-8.4%) | -$133.28M(+1.6%) |
| Mar 2023 | - | -$20.01M(-76.0%) | -$131.17M(-23.0%) |
| Dec 2022 | -$170.34M(-17.5%) | -$83.45M(+626.3%) | -$170.34M(+7.0%) |
| Sep 2022 | - | -$11.49M(-29.2%) | -$159.17M(-7.6%) |
| Jun 2022 | - | -$16.22M(-72.6%) | -$172.27M(-10.4%) |
| Mar 2022 | - | -$59.19M(-18.1%) | -$192.34M(-6.8%) |
| Dec 2021 | -$206.38M(-12.7%) | -$72.27M(+193.9%) | -$206.38M(+11.6%) |
| Sep 2021 | - | -$24.59M(-32.2%) | -$184.99M(-8.7%) |
| Jun 2021 | - | -$36.29M(-50.4%) | -$202.69M(+0.8%) |
| Mar 2021 | - | -$73.22M(+43.9%) | -$200.99M(-15.0%) |
| Dec 2020 | -$236.52M(-12.5%) | -$50.89M(+20.3%) | -$236.52M(-7.0%) |
| Sep 2020 | - | -$42.29M(+22.3%) | -$254.38M(-6.3%) |
| Jun 2020 | - | -$34.59M(-68.2%) | -$271.62M(-8.8%) |
| Mar 2020 | - | -$108.75M(+58.2%) | -$297.69M(+10.1%) |
| Dec 2019 | -$270.43M(-11.7%) | -$68.76M(+15.5%) | -$270.43M(+2.4%) |
| Sep 2019 | - | -$59.53M(-1.8%) | -$264.08M(-22.3%) |
| Jun 2019 | - | -$60.65M(-25.6%) | -$340.01M(+0.8%) |
| Mar 2019 | - | -$81.49M(+30.6%) | -$337.41M(+10.2%) |
| Dec 2018 | -$306.26M(+40.3%) | -$62.41M(-53.9%) | -$306.26M(-3.7%) |
| Sep 2018 | - | -$135.45M(+133.3%) | -$318.01M(+36.7%) |
| Jun 2018 | - | -$58.06M(+15.3%) | -$232.58M(+6.7%) |
| Mar 2018 | - | -$50.34M(-32.1%) | -$217.99M(-0.1%) |
| Dec 2017 | -$218.22M(+39.8%) | -$74.16M(+48.3%) | -$218.22M(+23.9%) |
| Sep 2017 | - | -$50.02M(+15.1%) | -$176.09M(+4.9%) |
| Jun 2017 | - | -$43.46M(-14.1%) | -$167.85M(+5.7%) |
| Mar 2017 | - | -$50.58M(+57.9%) | -$158.86M(+1.8%) |
| Dec 2016 | -$156.10M(+48.7%) | -$32.03M(-23.4%) | -$156.10M(-3.7%) |
| Sep 2016 | - | -$41.79M(+21.3%) | -$162.15M(+14.0%) |
| Jun 2016 | - | -$34.47M(-27.9%) | -$142.19M(+8.5%) |
| Mar 2016 | - | -$47.81M(+25.6%) | -$131.04M(+24.9%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2015 | -$104.96M(+102.2%) | -$38.08M(+74.4%) | -$104.96M(+28.9%) |
| Sep 2015 | - | -$21.83M(-6.3%) | -$81.43M(+8.9%) |
| Jun 2015 | - | -$23.31M(+7.3%) | -$74.78M(+18.0%) |
| Mar 2015 | - | -$21.73M(+49.3%) | -$63.38M(+22.1%) |
| Dec 2014 | -$51.91M(+11.7%) | -$14.55M(-4.1%) | -$51.91M(+14.0%) |
| Sep 2014 | - | -$15.18M(+27.5%) | -$45.52M(+3.6%) |
| Jun 2014 | - | -$11.91M(+16.1%) | -$43.92M(+3.4%) |
| Mar 2014 | - | -$10.26M(+25.6%) | -$42.48M(-8.6%) |
| Dec 2013 | -$46.49M(+22.1%) | -$8.17M(-39.9%) | -$46.49M(+1.4%) |
| Sep 2013 | - | -$13.58M(+29.8%) | -$45.85M(+15.5%) |
| Jun 2013 | - | -$10.46M(-26.7%) | -$39.70M(-3.7%) |
| Mar 2013 | - | -$14.27M(+89.5%) | -$41.22M(+8.3%) |
| Dec 2012 | -$38.07M(-25.1%) | -$7.53M(+1.4%) | -$38.07M(-13.6%) |
| Sep 2012 | - | -$7.43M(-38.0%) | -$44.08M(-11.6%) |
| Jun 2012 | - | -$11.99M(+7.8%) | -$49.86M(+2.6%) |
| Mar 2012 | - | -$11.12M(-17.9%) | -$48.59M(-4.4%) |
| Dec 2011 | -$50.84M(+253.9%) | -$13.54M(+2.6%) | -$50.84M(+236.2%) |
| Sep 2011 | - | -$13.20M(+23.2%) | -$15.12M(+16.0%) |
| Jun 2011 | - | -$10.72M(-19.9%) | -$13.04M(-8.5%) |
| Mar 2011 | - | -$13.38M(-160.3%) | -$14.25M(-0.8%) |
| Dec 2010 | -$14.37M(-68.2%) | $22.18M(-299.4%) | -$14.37M(-69.6%) |
| Sep 2010 | - | -$11.12M(-6.7%) | -$47.22M(-1.3%) |
| Jun 2010 | - | -$11.92M(-11.7%) | -$47.85M(+1.5%) |
| Mar 2010 | - | -$13.50M(+26.4%) | -$47.16M(+4.4%) |
| Dec 2009 | -$45.18M(+14.3%) | -$10.68M(-9.2%) | -$45.18M(-9.3%) |
| Sep 2009 | - | -$11.76M(+4.7%) | -$49.80M(+7.6%) |
| Jun 2009 | - | -$11.23M(-2.5%) | -$46.28M(+5.9%) |
| Mar 2009 | - | -$11.52M(-24.7%) | -$43.69M(+10.5%) |
| Dec 2008 | -$39.53M(-372.2%) | -$15.30M(+86.0%) | -$39.53M(-319.7%) |
| Sep 2008 | - | -$8.23M(-4.8%) | $17.99M(-10.3%) |
| Jun 2008 | - | -$8.64M(+17.4%) | $20.05M(+10.8%) |
| Mar 2008 | - | -$7.36M(-117.4%) | $18.11M(+24.7%) |
| Dec 2007 | $14.52M(-140.4%) | $42.22M(-784.2%) | $14.52M(-152.4%) |
| Sep 2007 | - | -$6.17M(-41.7%) | -$27.70M(+28.7%) |
| Jun 2007 | - | -$10.59M(-3.2%) | -$21.53M(+96.8%) |
| Mar 2007 | - | -$10.94M | -$10.94M |
| Dec 2006 | -$35.92M(+69.7%) | - | - |
| Dec 2005 | -$21.16M | - | - |
FAQ
- What is Amicus Therapeutics annual free cash flow?
- What is the all time high annual FCF for Amicus Therapeutics?
- What is Amicus Therapeutics annual FCF year-on-year change?
- What is Amicus Therapeutics quarterly free cash flow?
- What is the all time high quarterly FCF for Amicus Therapeutics?
- What is Amicus Therapeutics quarterly FCF year-on-year change?
- What is Amicus Therapeutics TTM free cash flow?
- What is the all time high TTM FCF for Amicus Therapeutics?
- What is Amicus Therapeutics TTM FCF year-on-year change?
What is Amicus Therapeutics annual free cash flow?
The current annual FCF of FOLD is -$37.44M
What is the all time high annual FCF for Amicus Therapeutics?
Amicus Therapeutics all-time high annual free cash flow is $14.52M
What is Amicus Therapeutics annual FCF year-on-year change?
Over the past year, FOLD annual free cash flow has changed by +$39.09M (+51.07%)
What is Amicus Therapeutics quarterly free cash flow?
The current quarterly FCF of FOLD is $7.55M
What is the all time high quarterly FCF for Amicus Therapeutics?
Amicus Therapeutics all-time high quarterly free cash flow is $42.22M
What is Amicus Therapeutics quarterly FCF year-on-year change?
Over the past year, FOLD quarterly free cash flow has changed by +$39.05M (+123.95%)
What is Amicus Therapeutics TTM free cash flow?
The current TTM FCF of FOLD is $1.61M
What is the all time high TTM FCF for Amicus Therapeutics?
Amicus Therapeutics all-time high TTM free cash flow is $20.05M
What is Amicus Therapeutics TTM FCF year-on-year change?
Over the past year, FOLD TTM free cash flow has changed by +$89.63M (+101.83%)